FDA approves new Novartis drug for rare type of pancreatic cancer (Morning Read)

Among today’s current medical news: Novartis wins FDA approval on a new pancreatic cancer drug; Vermont on its way to introducing single payer health care system; one nurses strike in California starts while another in Massachusetts is averted; and sex, coffee and six other things that can kill you, according to a new study.

Current medical news and unique business news for anyone who cares about the healthcare industry.

New pancreatic tumor drug: Novartis (NYSE:NVS) has received Food and Drug Administration approval on Afinitor for treating a rare type of pancreatic tumor. Afinitor is the first new drug in 30 years approved to treat patients with advanced pancreatic neuroendocrine tumors. These tumors grow more slowly than other pancreatic cancers, but they also have few treatment options. The drug is already approved for treating kidney cancer. Thomson Reuters projects Afinitor sales could reach sales of $1.3 billion in 2015. Novartis also has applications pending in Europe for use of the drug to treat pancreatic cancer.

Nurses strike: Registered nurses at Children’s Hospital in Oakland, California went on a five-day strike to protest proposals that include paying more for their health insurance. But a strike at Tufts Medical Center in Boston was averted after a last-minute deal.

Single payer health care: Vermont is on its way to introducing a single payer health care system. Legislation creating the system awaits the governor’s signature. But the state still needs to find a way to pay for it, Vermont Public Radio reports.

PerkinElmer acquisition: PerkinElmer acquires Geospiza, a company whose cloud-based software is used for managing genetic analysis and laboratory workflows.

Sex, coffee… and six other things are listed in a new new study as triggers for a burst brain aneurysm. People who have aneursyms are advised to avoid these triggering activities. Hey, is work on that list?